Citi added KLA-Tencor (KLAC) to Top Picks Live, Removes Lam Research (LRCX)
- Mega Gold Merger Breaks Down
- Pfizer, Inc. (PFE) Said to Recently Hold Talks to Acquire AstraZeneca (AZN)
- Halliburton Co. (HAL) Tops Q1 EPS by 1c; Sees Q2 EPS Up 25%
- Tesla Motors (TSLA) Plans to Start Manufacturing in China Within 3 to 4 Years - Musk
- Sarepta (SRPT) Plans to Submit NDA for Eteplirsen by End of 2014
Citi added KLA-Tencor (Nasdaq: KLAC) to its Top Picks Live List, while removing Lam Research (Nasdaq: LRCX).
You May Also Be Interested In
- UPDATE: Cantor Fitzgerald Starts Applied Genetic Technologies Corp. (AGTC) at Buy
- Cantor Fitzgerald Upgrades Zimmer Holdings (ZMH) to Buy
- Piper Jaffray Upgrades Big Lots (BIG) to Overweight
Create E-mail Alert Related CategoriesAnalyst Comments
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!